Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NPWT patient outreach

This article was originally published in The Gray Sheet

Executive Summary

Smith & Nephew is launching a negative pressure wound therapy hotline for patients. Announced June 7, the hotline (1-866-998-NPWT) was previously only available to clinicians, but now patients can speak to dedicated support staff about the company's Renasys NPWT products. "The clinical hotline is a component of our investment in a comprehensive program to support the patient receiving NPWT in the home and further support appropriate product utilization and patient education," said Patricia Burns, senior director of clinical affairs. Smith & Nephew recently lost a patent infringement suit brought by V.A.C maker Kinetic Concepts relating to its Renasys-F foam dressing kit, but the firm is appealing the verdict (1"The Gray Sheet" March 15, 2010)
Advertisement

Related Content

KCI Wins Negative Pressure Wound Therapy Patent Suit Over Smith & Nephew
KCI Wins Negative Pressure Wound Therapy Patent Suit Over Smith & Nephew

Topics

Advertisement
UsernamePublicRestriction

Register

MT029008

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel